Biruete Annabel, Chen Neal X, Metzger Corinne E, Srinivasan Shruthi, Oâ Neill Kalisha, Fallen Paul B, Fonseca Austin, Wilson Hannah E, de Loor Henriette, Evenepoel Pieter, Swanson Kelly S, Allen Matthew R, Moe Sharon M
bioRxiv. 2023 Jan 31:2023.01.29.526093. doi: 10.1101/2023.01.29.526093.
Dietary fiber is important for a healthy diet, but intake is low in CKD patients and the impact this has on the manifestations of CKD-Mineral Bone Disorder (MBD) is unknown.
The Cy/+ rat with progressive CKD was fed a casein-based diet of 0.7% phosphate with 10% inulin (fermentable fiber) or cellulose (non-fermentable fiber) from 22 weeks to either 30 or 32 weeks of age (~30 and ~15 % of normal kidney function). We assessed CKD-MBD, cecal microbiota, and serum gut-derived uremic toxins. Two-way ANOVA was used to evaluate the effect of age and inulin diet, and their interaction.
In CKD animals, dietary inulin led to changes in microbiota alpha and beta diversity at 30 and 32 weeks, with higher relative abundance of several taxa, including and , and lower . Inulin reduced serum levels of gut-derived uremic toxins, phosphate, and parathyroid hormone, but not fibroblast growth factor-23. Dietary inulin decreased aorta and cardiac calcification and reduced left ventricular mass index and cardiac fibrosis. Bone turnover and cortical bone parameters were improved with inulin; however, bone mechanical properties were not altered.
The addition of the fermentable fiber inulin to the diet of CKD rats led to changes in the gut microbiota composition, lowered gut-derived uremic toxins, and improved most parameters of CKD-MBD. Future studies should assess this fiber as an additive therapy to other pharmacologic and diet interventions in CKD.
Dietary fiber has well established beneficial health effects. However, the impact of fermentable dietary fiber on the intestinal microbiome and CKD-MBD is poorly understood. We used an animal model of progressive CKD and demonstrated that the addition of 10% of the fermentable fiber inulin to the diet altered the intestinal microbiota and lowered circulating gut-derived uremic toxins, phosphorus, and parathyroid hormone. These changes were associated with improved cortical bone parameters, lower vascular calcification, and reduced cardiac hypertrophy, fibrosis and calcification. Taken together, dietary fermentable fiber may be a novel additive intervention to traditional therapies of CKD-MBD.
膳食纤维对健康饮食很重要,但慢性肾脏病(CKD)患者的膳食纤维摄入量较低,且其对CKD - 矿物质骨病(MBD)表现的影响尚不清楚。
将患有进行性CKD的Cy/+大鼠从22周龄喂至30或32周龄(约为正常肾功能的30%和15%),给予基于酪蛋白的饮食,其中含0.7%的磷酸盐以及10%的菊粉(可发酵纤维)或纤维素(不可发酵纤维)。我们评估了CKD - MBD、盲肠微生物群和血清肠道源性尿毒症毒素。采用双向方差分析来评估年龄和菊粉饮食的影响及其相互作用。
在CKD动物中,饮食中的菊粉在30周和32周时导致微生物群α和β多样性发生变化,几种分类群的相对丰度较高,包括[具体分类群1]和[具体分类群2],而[具体分类群3]较低。菊粉降低了血清中肠道源性尿毒症毒素、磷酸盐和甲状旁腺激素的水平,但未降低成纤维细胞生长因子23的水平。饮食中的菊粉减少了主动脉和心脏钙化,并降低了左心室质量指数和心脏纤维化。菊粉改善了骨转换和皮质骨参数;然而,骨力学性能未改变。
在CKD大鼠饮食中添加可发酵纤维菊粉会导致肠道微生物群组成发生变化,降低肠道源性尿毒症毒素,并改善CKD - MBD的大多数参数。未来的研究应评估这种纤维作为CKD其他药物和饮食干预的辅助治疗方法。
膳食纤维对健康具有公认的有益作用。然而,可发酵膳食纤维对肠道微生物群和CKD - MBD的影响尚不清楚。我们使用进行性CKD动物模型证明,在饮食中添加10%的可发酵纤维菊粉可改变肠道微生物群,降低循环中的肠道源性尿毒症毒素、磷和甲状旁腺激素。这些变化与改善皮质骨参数、降低血管钙化以及减少心脏肥大、纤维化和钙化有关。综上所述,饮食中的可发酵纤维可能是CKD - MBD传统治疗的一种新型辅助干预措施。